Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Antibody

Este producto es parte de KDR - kinase insert domain receptor
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx110345
tested applications
ELISA, IHC

Description

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2/KDR) Antibody is a Rabbit Polyclonal antibody against Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2/KDR). Recombinant Human VEGFR2 ProteinTyrosine-Protein Kinase That Acts As A Cell-Surface Receptor For Vegfa, Vegfc And VegfdPlays An Essential Role In The Regulation Of Angiogenesis, Vascular Development, Vascular Permeability, And Embryonic HematopoiesisPromotes ProlifeRation, Survival, MigRation And Differentiation Of Endothelial CellsPromotes Reorganization Of The Actin CytoskeletonIsoforms Lacking A Transmembrane Domain, Such As Isoform 2 And Isoform 3, May Function As Decoy Receptors For Vegfa, Vegfc And/Or VegfdIsoform 2 Plays An Important Role As Negative Regulator Of Vegfa- And Vegfc-Mediated Lymphangiogenesis By Limiting The Amount Of Free Vegfa And/Or Vegfc And Preventing Their Binding To Flt4Modulates Flt1 And Flt4 Signaling By Forming HeterodimersBinding Of Vascular Growth Factors To Isoform 1 Leads To The Activation Of Several Signaling CascadesActivation Of Plcg1 Leads To The Production Of The Cellular Signaling Molecules Diacylglycerol And Inositol 1,4,5-Trisphosphate And The Activation Of Protein Kinase CMediates Activation Of Mapk1/Erk2, Mapk3/Erk1 And The Map Kinase Signaling Pathway, As Well As Of The Akt1 Signaling PathwayMediates Phosphorylation Of Pik3R1, The Regulatory Subunit Of Phosphatidylinositol 3-Kinase, Reorganization Of The Actin Cytoskeleton And Activation Of Ptk2/Fak1Required For Vegfa-Mediated Induction Of Nos2 And Nos3, Leading To The Production Of The Signaling Molecule Nitric Oxide (No) By Endothelial CellsPhosphorylates Plcg1Promotes Phosphorylation Of Fyn, Nck1, Nos3, Pik3R1, Ptk2/Fak1 And Src.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetVascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR)
HostRabbit
ReactivityHuman
Recommended DilutionIHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
Purity> 95%
PurificationPurified by Protein G.
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
FormLiquid
Tested ApplicationsELISA, IHC
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP35968
Gene ID3791
NCBI AccessionNP_002244.1, NM_002253.2
OMIM191306
AliasFLK1,CD309,VEGFR,VEGFR2,VEGFR-2,Protein-tyrosine kinase receptor flk-1,Fetal liver kinase 1,Vascular endothelial growth factor receptor 2
BackgroundAntibody anti-KDR
StatusRUO

Descripción

KDR, also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a critical protein in the regulation of angiogenesis and vascular development. This receptor tyrosine kinase (RTK) is encoded by the KDR gene located on chromosome 4q12 in humans. KDR is a member of the VEGF receptor family, which plays an essential role in the processes of vasculogenesis and angiogenesis by mediating the cellular responses to the vascular endothelial growth factor (VEGF). The VEGF family consists of several ligands, with VEGF-A being the primary ligand for KDR. KDR is predominantly expressed in endothelial cells, where it regulates vascular permeability, endothelial cell proliferation, migration, and survival. Due to its pivotal role in vascular biology, KDR has been extensively studied in the context of cancer, where angiogenesis is a crucial process for tumor growth and metastasis. KDR's involvement in pathological angiogenesis makes it a significant target for anti-angiogenic therapies in cancer treatment. Moreover, it has implications in other diseases characterized by abnormal vascular growth, such as age-related macular degeneration and rheumatoid arthritis.

Related Products

EH0329

Human VEGFR2/KDR(Vascular endothelial growth factor receptor 2) ELISA Kit

Ver Producto
EM1445

Mouse VEGFR-2/KDR(Vascuoar Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto
ER1426

Rat VEGFR-2/KDR(Vascular Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto